1. Overview of Management of Intermediate- and High-Risk Pulmonary Embolism.
- Author
-
Tapson VF and Weinberg AS
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Risk Factors, Treatment Outcome, Critical Care standards, Fibrinolytic Agents therapeutic use, Practice Guidelines as Topic, Pulmonary Embolism diagnosis, Pulmonary Embolism therapy, Thrombolytic Therapy standards
- Abstract
Anticoagulation is the cornerstone of acute pulmonary embolism (PE) therapy. Intermediate-risk (submassive) or high-risk (massive) PE patients have higher mortality than low-risk patients. It is generally accepted that high-risk PE patients should be considered for more aggressive therapy. Intermediate-risk patients can be subdivided, although more than simply categorizing the patient is required to guide therapy. Therapeutic approaches depend on a prompt, detailed evaluation, and PE response teams may help with rapid assessment and initiation of therapy. More clinical trial data are needed to guide clinicians in the management of acute intermediate- and high-risk PE patients., Competing Interests: Disclosure Authors have nothing to disclose., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF